表紙
市場調查報告書
商品編碼
1071761

特應性皮炎治療的全球市場規模:按產品、適應症、最終用途行業和地區劃分的預測(2022-2028 年)

Global Atopic Dermatitis Treatment Market Size study, by Product by Indication by end use industries and Regional Forecasts 2022-2028

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

特應性皮炎藥物的全球市場正在擴大,主要是由於皮膚病患病率增加以及醫療保健行業研發活動增加等因素。

此外,由於可支配收入的增加和醫療費用的增加,對特應性皮炎治療藥物的引入和需求預計將增加預測期內的市場增長。

然而,特應性皮炎藥物的高成本和缺乏保修政策預計將阻礙 2022-2028 年預測期內的市場增長。

本報告按產品、適應症、最終用途行業、地區調查了全球特應性皮炎藥物市場、市場概況、行業分析、風險評估。它提供了分析、競爭信息等。

目錄

第 1 章執行摘要

第 2 章全球特應性皮炎治療市場:定義和範圍

第三章全球特應性皮炎治療藥物市場:市場動態

  • 特應性皮炎藥物市場:影響分析(2020-2028)

第四章全球特應性皮炎治療藥物市場:行業分析

  • 波特五力模型
  • PEST 分析
  • 投資採用模式
  • 分析師建議和結論
  • 主要投資機會
  • 關鍵成功策略

第 5 章風險評估:COVID-19 的影響

    • 評估 COVID-19 對行業的整體影響
    • COVID-19 之前和之後的市場情景

第 6 章全球特應性皮炎治療藥物市場:按產品分類

  • 市場快照
  • 成就-潛力分析
  • 估計/預測(2018-2028)
  • 細分分析
    • 皮質類固醇
    • 鈣調神經磷酸□抑製劑
    • 免疫抑製劑
    • 生物治療
    • PDE-4抑製劑
    • 抗生素
    • 抗組胺藥
    • 潤膚劑(保濕劑)

第7章全球特應性皮炎治療藥物市場:按適應症

  • 市場快照
  • 成就-潛力分析
  • 估計/預測(2018-2028)
  • 細分分析
    • 本地
    • 口語
    • 注入

第 8 章全球特應性皮炎治療藥物市場:按最終用途行業分列

  • 市場快照
  • 成就-潛力分析
  • 估計/預測(2018-2028)
  • 細分分析
    • 院內藥房
    • 零售藥店
    • 網上藥店
    • 藥店
    • 郵購藥房
    • 診所(皮膚科)

第9章全球特應性皮炎治療藥物市場:區域分析

  • 區域市場概況
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 世界其他地區

第10章衝突信息

  • 主要市場策略
  • 公司簡介
    • Sanofi SA Ltd.
    • Galderma SA Pvt Ltd.
    • Allergan Plc.
    • Novartis AG Ltd.
    • Bristol-Myers Squibb Ltd.
    • Bayer AG Ltd.
    • Meda Pharmaceuticals Pvt Ltd.
    • Astellas Pharma Inc.
    • Anacor Pharmaceutical Inc.
    • Regeneron Pharmaceuticals, Inc

第11章 調查流程

目錄

Global Atopic Dermatitis Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Atopic dermatitis (AD) is chronic inflammatory skin condition that usually affects the face (cheeks), neck, arms, and legs. It also usually spreads to the groin areas. Atopic dermatitis (AD) is common worldwide. People of all ages from newborns to adults 65 years of age and older live with this condition. Growing prevalence of dermatological skin disorders and rising Research & Development activities in healthcare industry are key drivers for the growth of Atopic Dermatitis Treatment market. For instance, according to National Eczema Association (NEA)- as of 2020 around 31.6 million people (10.1%) in the U.S. are suffering from some type of eczema. And approximately 9.6 million U.S. children under the age of 18 have AD, and one-third have moderate to severe disease. Furthermore, on January 5th , 2022, Swiss pharmaceutical company specializing in dermatological treatments and skin care products Galderma has acquired ALASTIN Skincare, Inc., a California based pharmaceuticals company and on January 14th , 2022, American biopharmaceutical company AbbVie has got approval from the U.S. Food and Drug Administration (FDA) for its new product RINVOQ for the treatment of moderate to severe atopic dermatitis in adults and children 12 years of age and older. Also, with the increasing disposable income and rising healthcare spending, the adoption & demand for Atopic Dermatitis Treatment is likely to increase the market growth during the forecast period. However, high cost of Atopic Dermatitis Treatment and lack of reimbursement policies impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Atopic Dermatitis Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share owing to increasing prevalence of skin disorders and presence of leading market players in the region. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate over the forecast period 2021-2027. Factors such as growing healthcare infrastructure and increasing prevalence of skin diseases among elder population in the region would create lucrative growth prospects for the Atopic Dermatitis Treatment market across Asia-Pacific region.

Major market player included in this report are:

Sanofi SA Ltd.

Galderma SA Pvt Ltd.

Allergan Plc.

Novartis AG Ltd.

Bristol-Myers Squibb Ltd.

Bayer AG Ltd.

Meda Pharmaceuticals Pvt Ltd.

Astellas Pharma Inc.

Anacor Pharmaceutical Inc.

Regeneron Pharmaceuticals, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Corticosteroids

Calcineurin Inhibitors

Immunosuppressants

Biologic Therapy

PDE-4 Inhibitor

Antibiotics

Antihistamines

Emollients

By Indication:

Topical

Oral

Injectable

By End Use Industries:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Drug Stores

Mail Order Pharmacies

Dermatology Clinics

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019,2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Atopic Dermatitis Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Atopic Dermatitis Treatment Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Atopic Dermatitis Treatment Market, by Product, 2020-2028 (USD Billion)
    • 1.2.3. Atopic Dermatitis Treatment Market, by Indication, 2020-2028 (USD Billion)
    • 1.2.4. Atopic Dermatitis Treatment Market, by End Use Industries, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Atopic Dermatitis Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Atopic Dermatitis Treatment Market Dynamics

  • 3.1. Atopic Dermatitis Treatment Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of dermatological skin disorders.
      • 3.1.1.2. Rising Research & Development activities in healthcare industry.
    • 3.1.2. Market Challenges
      • 3.1.2.1. high treatment cost.
      • 3.1.2.2. Lack of reimbursement policies.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. increasing spending on healthcare.
      • 3.1.3.2. Rising disposable income.

Chapter 4. Global Atopic Dermatitis Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Atopic Dermatitis Treatment Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Atopic Dermatitis Treatment Market by Product, Performance - Potential Analysis
  • 6.3. Global Atopic Dermatitis Treatment Market Estimates & Forecasts by Product 2018-2028 (USD Billion)
  • 6.4. Atopic Dermatitis Treatment Market, Sub Segment Analysis
    • 6.4.1. Corticosteroids
    • 6.4.2. Calcineurin Inhibitors
    • 6.4.3. Immunosuppressants
    • 6.4.4. Biologic Therapy
    • 6.4.5. PDE-4 Inhibitor
    • 6.4.6. Antibiotics
    • 6.4.7. Antihistamines
    • 6.4.8. Emollients

Chapter 7. Global Atopic Dermatitis Treatment Market, by Indication

  • 7.1. Market Snapshot
  • 7.2. Global Atopic Dermatitis Treatment Market by Indication, Performance - Potential Analysis
  • 7.3. Global Atopic Dermatitis Treatment Market Estimates & Forecasts by Indication 2018-2028 (USD Billion)
  • 7.4. Atopic Dermatitis Treatment Market, Sub Segment Analysis
    • 7.4.1. Topical
    • 7.4.2. Oral
    • 7.4.3. Injectable

Chapter 8. Global Atopic Dermatitis Treatment Market, by End Use Industries

  • 8.1. Market Snapshot
  • 8.2. Global Atopic Dermatitis Treatment Market by End Use Industries, Performance - Potential Analysis
  • 8.3. Global Atopic Dermatitis Treatment Market Estimates & Forecasts by End Use Industries 2018-2028 (USD Billion)
  • 8.4. Atopic Dermatitis Treatment Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Pharmacies
    • 8.4.4. Drug Stores
    • 8.4.5. Mail Order Pharmacies
    • 8.4.6. Dermatology Clinics

Chapter 9. Global Atopic Dermatitis Treatment Market, Regional Analysis

  • 9.1. Atopic Dermatitis Treatment Market, Regional Market Snapshot
  • 9.2. North America Atopic Dermatitis Treatment Market
    • 9.2.1. U.S. Atopic Dermatitis Treatment Market
      • 9.2.1.1. Product breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Indication breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. End Use Industries breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Atopic Dermatitis Treatment Market
  • 9.3. Europe Atopic Dermatitis Treatment Market Snapshot
    • 9.3.1. U.K. Atopic Dermatitis Treatment Market
    • 9.3.2. Germany Atopic Dermatitis Treatment Market
    • 9.3.3. France Atopic Dermatitis Treatment Market
    • 9.3.4. Spain Atopic Dermatitis Treatment Market
    • 9.3.5. Italy Atopic Dermatitis Treatment Market
    • 9.3.6. Rest of Europe Atopic Dermatitis Treatment Market
  • 9.4. Asia-Pacific Atopic Dermatitis Treatment Market Snapshot
    • 9.4.1. China Atopic Dermatitis Treatment Market
    • 9.4.2. India Atopic Dermatitis Treatment Market
    • 9.4.3. Japan Atopic Dermatitis Treatment Market
    • 9.4.4. Australia Atopic Dermatitis Treatment Market
    • 9.4.5. South Korea Atopic Dermatitis Treatment Market
    • 9.4.6. Rest of Asia Pacific Atopic Dermatitis Treatment Market
  • 9.5. Latin America Atopic Dermatitis Treatment Market Snapshot
    • 9.5.1. Brazil Atopic Dermatitis Treatment Market
    • 9.5.2. Mexico Atopic Dermatitis Treatment Market
  • 9.6. Rest of The World Atopic Dermatitis Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Sanofi SA Ltd.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Galderma SA Pvt Ltd.
    • 10.2.3. Allergan Plc.
    • 10.2.4. Novartis AG Ltd.
    • 10.2.5. Bristol-Myers Squibb Ltd.
    • 10.2.6. Bayer AG Ltd.
    • 10.2.7. Meda Pharmaceuticals Pvt Ltd.
    • 10.2.8. Astellas Pharma Inc.
    • 10.2.9. Anacor Pharmaceutical Inc.
    • 10.2.10. Regeneron Pharmaceuticals, Inc

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Atopic Dermatitis Treatment Market, report scope
  • TABLE 2. Global Atopic Dermatitis Treatment Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Atopic Dermatitis Treatment Market estimates & forecasts by Product 2018-2028 (USD Billion)
  • TABLE 4. Global Atopic Dermatitis Treatment Market estimates & forecasts by Indication 2018-2028 (USD Billion)
  • TABLE 5. Global Atopic Dermatitis Treatment Market estimates & forecasts by End Use Industries 2018-2028 (USD Billion)
  • TABLE 6. Global Atopic Dermatitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global Atopic Dermatitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global Atopic Dermatitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global Atopic Dermatitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Atopic Dermatitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Atopic Dermatitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Atopic Dermatitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Atopic Dermatitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Atopic Dermatitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. Global Atopic Dermatitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. U.S. Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 17. U.S. Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 18. U.S. Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 19. Canada Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 20. Canada Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. Canada Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. UK Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 23. UK Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. UK Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. Germany Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 26. Germany Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. Germany Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. RoE Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 29. RoE Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. RoE Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. China Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 32. China Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. China Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. India Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 35. India Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. India Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. Japan Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 38. Japan Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. Japan Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. RoAPAC Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. Brazil Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 44. Brazil Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. Brazil Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Mexico Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 47. Mexico Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. Mexico Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. RoLA Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 50. RoLA Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. RoLA Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. Row Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 53. Row Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. Row Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of Global Atopic Dermatitis Treatment Market
  • TABLE 56. List of primary sources, used in the study of Global Atopic Dermatitis Treatment Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Atopic Dermatitis Treatment Market, research methodology
  • FIG 2. Global Atopic Dermatitis Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Atopic Dermatitis Treatment Market, key trends 2021
  • FIG 5. Global Atopic Dermatitis Treatment Market, growth prospects 2022-2028
  • FIG 6. Global Atopic Dermatitis Treatment Market, porters 5 force model
  • FIG 7. Global Atopic Dermatitis Treatment Market, pest analysis
  • FIG 8. Global Atopic Dermatitis Treatment Market, value chain analysis
  • FIG 9. Global Atopic Dermatitis Treatment Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Atopic Dermatitis Treatment Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Atopic Dermatitis Treatment Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Atopic Dermatitis Treatment Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Atopic Dermatitis Treatment Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Atopic Dermatitis Treatment Market, regional snapshot 2018 & 2028
  • FIG 15. North America Atopic Dermatitis Treatment Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Atopic Dermatitis Treatment Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia pacific Atopic Dermatitis Treatment Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Atopic Dermatitis Treatment Market 2018 & 2028 (USD Billion)
  • FIG 19. Global Atopic Dermatitis Treatment Market, company Market share analysis (2021)